​US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India

Officials of the Union Health Ministry, along with the Drugs Controller General of India (DCGI) held a discussion with the representatives of Gilead Sciences on Wednesday to prepare a road map for introducing remdesivir in India, sources said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2LJtpNl
via IFTTT